Haloperidol-induced sudden cardiac arrest in a recently detected HIV and hepatitis C patient: A unique case report
Open Access
- 1 January 2023
- journal article
- research article
- Published by SAGE Publications in Sage Open Medical Case Reports
- Vol. 11
Abstract
We herein described a case of a 45-year-old male recently detected with HIV and Hepatitis C who presented with signs of sepsis, developed delirium, and received haloperidol. Surprisingly, 10 min after intravenous administration, the patient developed Torsades de pointes and required immediate resuscitation. The report discusses the limited instances of cardiac arrest linked to haloperidol use, despite its generally perceived safety. The patient had no apparent risk factors, emphasizing the need for increased caution when administering haloperidol, particularly in critically ill patients with HIV and Hepatitis C.Keywords
This publication has 17 references indexed in Scilit:
- QT interval prolongation and the risk of torsades de pointes: essentials for cliniciansCurrent Medical Research and Opinion, 2013
- The FDA extended warning for intravenous haloperidol and torsades de pointes: How should institutions respond?Journal of Hospital Medicine, 2010
- Antipsychotics for delirium2007
- Importance of hepatitis C coinfection in the development of QT prolongation in HIV-infected patientsJournal of Electrocardiology, 2006
- Cardiopulmonary arrest secondary to haloperidolThe American Journal of Emergency Medicine, 2000
- Cardiovascular Adverse Effects of Antipsychotic DrugsDrug Safety, 2000
- A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in FinlandActa Psychiatrica Scandinavica, 1991
- HALOPERIDOL AND CARDIAC ARRESTThe Lancet, 1988
- Adding up the Glasgow Coma Score1979
- ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESSThe Lancet, 1974